1. Home
  2. Active Ingredient Index
  3. Ustekinumab

Active Ingredient Ustekinumab

Active Ingredient Details

What is Ustekinumab?

A humanized monoclonal antibody that binds to IL-12 and IL-23 and is used as a DERMATOLOGIC AGENT in the treatment of patients with plaque PSORIASIS who have not responded to other therapies.

How many products in the NDC database contain Ustekinumab?

The NDC database has 51 products with the active ingredient Ustekinumab. The following table lists all the products that have this active ingredient.

NDC Products with Ustekinumab

NDC Proprietary Name Non-Proprietary Name Dosage Form Route Name Company Name Status
0143-9168Proprietary Name: Starjemza Ustekinumab-hmnyInjectionSubcutaneousHikma Pharmaceuticals Usa Inc.ACTIVE
0143-9169Proprietary Name: Starjemza Ustekinumab-hmnyInjectionSubcutaneousHikma Pharmaceuticals Usa Inc.ACTIVE
0143-9170Proprietary Name: Starjemza Ustekinumab-hmnyInjectionSubcutaneousHikma Pharmaceuticals Usa Inc.ACTIVE
0143-9171Proprietary Name: Starjemza Ustekinumab-hmnyInjectionIntravenousHikma Pharmaceuticals Usa Inc.ACTIVE
50090-7769Proprietary Name: Selarsdi Ustekinumab-aeknInjection, SolutionSubcutaneousA-s Medication SolutionsACTIVE
57894-054Proprietary Name: Stelara UstekinumabSolutionIntravenousJanssen Biotech, Inc.ACTIVE
57894-060Proprietary Name: Stelara UstekinumabInjection, SolutionSubcutaneousJanssen Biotech, Inc.ACTIVE
57894-061Proprietary Name: Stelara UstekinumabInjection, SolutionSubcutaneousJanssen Biotech, Inc.ACTIVE
57894-440Proprietary Name: Ustekinumab UstekinumabInjection, SolutionSubcutaneousJanssen Biotech, Inc.ACTIVE
57894-441Proprietary Name: Ustekinumab UstekinumabInjection, SolutionSubcutaneousJanssen Biotech, Inc.ACTIVE
57894-444Proprietary Name: Ustekinumab UstekinumabSolutionIntravenousJanssen Biotech, Inc.ACTIVE
61314-651Proprietary Name: Pyzchiva Ustekinumab-ttweInjection, SolutionSubcutaneousSandoz IncACTIVE
61314-652Proprietary Name: Pyzchiva Ustekinumab-ttweInjection, SolutionSubcutaneousSandoz IncACTIVE
61314-654Proprietary Name: Pyzchiva Ustekinumab-ttweInjection, SolutionIntravenousSandoz IncACTIVE
64538-824Proprietary Name: Ustekinumab-aauzInjectionRentschler Biopharma SeACTIVE
65219-822Proprietary Name: Otulfi Ustekinumab-aauzInjection, SolutionSubcutaneousFresenius Kabi Usa, LlcACTIVE
65219-824Proprietary Name: Otulfi Ustekinumab-aauzInjection, SolutionSubcutaneousFresenius Kabi Usa, LlcACTIVE
65219-826Proprietary Name: Otulfi Ustekinumab-aauzInjection, SolutionSubcutaneousFresenius Kabi Usa, LlcACTIVE
65219-828Proprietary Name: Otulfi Ustekinumab-aauzSolutionIntravenousFresenius Kabi Usa, LlcACTIVE
65219-862Proprietary Name: Ustekinumab-aauz Ustekinumab-aauzInjection, SolutionSubcutaneousFresenius Kabi Usa, LlcACTIVE
65219-866Proprietary Name: Ustekinumab-aauz Ustekinumab-aauzInjection, SolutionSubcutaneousFresenius Kabi Usa, LlcACTIVE
65267-896Proprietary Name: UstekinumabInjectionJanssen Pharmaceutical Sciences Unlimited CompanyACTIVE
68225-250Proprietary Name: Ustekinumab-ttweInjection, SolutionPatheon Italia S.p.aACTIVE
68225-251Proprietary Name: Ustekinumab-ttweInjection, SolutionPatheon Italia S.p.aACTIVE
68225-253Proprietary Name: Ustekinumab-ttweInjection, SolutionPatheon Italia S.p.aACTIVE
68225-272Proprietary Name: Ustekinumab-stbaInjection, SolutionPatheon Italia S.p.a.ACTIVE
68225-273Proprietary Name: Ustekinumab-stbaInjection, SolutionPatheon Italia S.p.a.ACTIVE
68225-284Proprietary Name: Ustekinumab-ttweInjection, SolutionPatheon Italia S.p.a.ACTIVE
70383-130Proprietary Name: UstekinumabInjection, Solution, ConcentrateBioconnection B.v.ACTIVE
72606-027Proprietary Name: Steqeyma Ustekinumab-stbaInjection, SolutionSubcutaneousCelltrion Usa, Inc.ACTIVE
72606-028Proprietary Name: Steqeyma Ustekinumab-stbaInjection, SolutionSubcutaneousCelltrion Usa, Inc.ACTIVE
72606-029Proprietary Name: Steqeyma Ustekinumab-stbaInjection, SolutionIntravenousCelltrion Usa, Inc.ACTIVE
72606-060Proprietary Name: Steqeyma Ustekinumab-stbaInjection, SolutionSubcutaneousCelltrion Usa, Inc.ACTIVE
82009-160Proprietary Name: Ustekinumab-ttwe Ustekinumab-ttweInjection, SolutionSubcutaneousQuallent Pharmaceuticals Health LlcACTIVE
82009-161Proprietary Name: Ustekinumab-ttwe Ustekinumab-ttweInjection, SolutionSubcutaneousQuallent Pharmaceuticals Health LlcACTIVE
82009-162Proprietary Name: Ustekinumab-ttwe Ustekinumab-ttweInjection, SolutionSubcutaneousQuallent Pharmaceuticals Health LlcACTIVE
82009-163Proprietary Name: Ustekinumab-ttwe Ustekinumab-ttweInjection, SolutionIntravenousQuallent Pharmaceuticals Health LlcACTIVE
82507-004Proprietary Name: UstekinumabSolutionAgc Biologics A/sACTIVE
83257-023Proprietary Name: Yesintek UstekinumabInjection, SolutionSubcutaneousBiocon Biologics Inc.ACTIVE
83257-024Proprietary Name: Yesintek UstekinumabInjection, SolutionSubcutaneousBiocon Biologics Inc.ACTIVE
83257-025Proprietary Name: Yesintek UstekinumabInjection, SolutionSubcutaneousBiocon Biologics Inc.ACTIVE
83257-026Proprietary Name: Yesintek UstekinumabSolutionIntravenousBiocon Biologics Inc.ACTIVE
83457-651Proprietary Name: Pyzchiva Ustekinumab-ttweInjection, SolutionSubcutaneousCordavis LimitedACTIVE
83457-652Proprietary Name: Pyzchiva Ustekinumab-ttweInjection, SolutionSubcutaneousCordavis LimitedACTIVE
84612-055Proprietary Name: Wezlana Ustekinumab-auubInjection, SolutionSubcutaneousNuvaila LimitedACTIVE
84612-066Proprietary Name: Wezlana Ustekinumab-auubInjection, SolutionIntravenousNuvaila LimitedACTIVE
84612-076Proprietary Name: Wezlana Ustekinumab-auubInjection, SolutionSubcutaneousNuvaila LimitedACTIVE
84612-089Proprietary Name: Wezlana Ustekinumab-auubInjection, SolutionSubcutaneousNuvaila LimitedACTIVE
84612-855Proprietary Name: Wezlana Ustekinumab-auubInjection, SolutionSubcutaneousNuvaila LimitedACTIVE
84612-876Proprietary Name: Wezlana Ustekinumab-auubInjection, SolutionSubcutaneousNuvaila LimitedACTIVE
84612-889Proprietary Name: Wezlana Ustekinumab-auubInjection, SolutionSubcutaneousNuvaila LimitedACTIVE
<